Efficacy and safety of empagliflozin in GSD type Ib: data from an international questionnaire survey | Webinar Recording
10th May 2022
Description
A paediatric metabolic specialist presents international data on the growing use of empagliflozin to manage neutropenia in GSD type Ib.
